title: [The probiotic correction of microecological and immune disorders in gastroduodenal pathology in children].
abstract: The state of microbiocenosis was studied and the level of immunoglobulins was determined in the gastric juice and feces of children with chronic diseases of the digestive system. In 20% of patients an increase in the contamination of the gastric biotope with opportunistic microflora was established. The isolation rate of Helicobacter pylori was 56%. The detection of H. pylori was found to be accompanied by the aggravation of the form and course of gastritis. In cases of Helicobacter-associated pathology the deficiency of Lactobacillus sp. in the stomach was established, which was accompanied by their deficiency and absence in feces. The study also revealed a decrease in the population level of Bifidobacterium sp. with a simultaneous increase in the population of opportunistic enterobacteria and changes in the state of local immunity: the decreased level of SIgA in most samples and the decreased level of IgG in the presence of H. pylori. The correction of microecological and immune disturbances with probiotic preparations, containing bifidobacteria (bifidumbacterin-forte) and lactobacilli, yielded good results.
authors.forename: E A
authors.initials: EA
authors.lastname: Lykova
authors.forename: V M
authors.initials: VM
authors.lastname: Bondarenko
authors.forename: Iu A
authors.initials: IuA
authors.lastname: Izachik
authors.forename: N A
authors.initials: NA
authors.lastname: Izachik
authors.forename: A V
authors.initials: AV
authors.lastname: Grigor'ev
authors.forename: A O
authors.initials: AO
authors.lastname: Murashov
authors.forename: N A
authors.initials: NA
authors.lastname: Abramov
mesh_terms: D000293:Adolescent; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D001430:Bacteriocins / Q000627:therapeutic use*; D001688:Biological Products / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D002908:Chronic Disease; D003131:Combined Modality Therapy; D004341:Drug Evaluation; D004378:Duodenal Diseases / Q000188:drug therapy* / Q000276:immunology / Q000382:microbiology; D004463:Ecology; D006801:Humans; D007154:Immune System Diseases / Q000188:drug therapy* / Q000276:immunology / Q000382:microbiology; D007223:Infant; D012871:Skin Diseases / Q000188:drug therapy; D013272:Stomach Diseases / Q000188:drug therapy* / Q000276:immunology / Q000382:microbiology
chemical_list: D000890:Anti-Infective Agents; D001430:Bacteriocins; D001688:Biological Products; C008244:lactobacterin; C010546:bifidobacterin
vernacular_title: Korrektsiia probiotikami mikroékologicheskikh i immunnykh narusheniĭ pri gastroduodenal'noĭ patologii u deteĭ.